Background: There is increasing evidence to show the clinical implications
of membrane biocompatibility in haemodialysis therapy. Methods: We conducte
d a crossover clinical study examining the clinical biocompatibility profil
e of three derivatised cellulosic membranes obtained by means of different
modifications to the cellulose polymer (haemophan, cellulose diacetate, ben
zyl cellulose) in comparison to the parent polymer (cuprophan) and a refere
nce synthetic membrane (polysulfone). Results: In terms of leukopenia produ
ction, derivatised cellulosic membranes were generally intermediate between
cuprophan and polysulfone, haemophan being more marked than the other two
membranes. Upregulation of CD11b/CD18 molecule on neutrophils was found wit
h all membranes, to a greater extent with the dialyser containing cuprophan
. The expression of CD11b/CD18 on monocytes was slightly affected with cupr
ophan only. The neutrophil and monocyte counts throughout the entire dialys
is session showed a much better correlation with the cellular expression of
sialyl-Lewis x (CD15s) molecule than with CD11b/CD18 expression. An increa
sed formation of platelet-neutrophil coaggregates occurred at 15 and 30 min
during dialysis with all membranes but benzyl cellulose, the increase with
cuprophan being higher than with the other membranes. In concomitance with
the increase in platelet-neutrophil coaggregation, an increased hydrogen p
eroxide production by neutrophils occurred, which proved to be significantl
y higher compared to the unchanged neutrophil hydrogen peroxide production
during HD with benzyl cellulose. Conclusions: Our results demonstrate that
derivatised cellulose is associated with a considerable improvement in the
clinical biocompatibility profile. Derivatised cellulosic membranes show ma
ny similarities but also several significant differences which very likely
stem from the different type of structural modification to the cellulose po
lymer rather than from the degree of hydroxyl group replacement.